BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma & Biopharma Manufacturing

Fosun Pharma Licenses XH-S004 to Expedition in US$645M Deal

Fosun Pharma announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) t...

August 13, 2025 | News

Sartorius Stedim Biotech Partners with Nanotein to Advance Immune Cell Manufacturing with NanoSpark® Reagents

Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement for...

August 12, 2025 | News

ProBio Launches GMP AAV Manufacturing Services at New Jersey Facility to Accelerate Gene Therapy Development

ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, announced the launch of its cGMP Adeno-...

August 12, 2025 | News

RemeGen Secures FDA Clearance for Phase II Trials of Innovative Bispecific Antibody RC148 in Advanced Solid Tumors

RemeGen Co., announces clearance of IND application by Food and Drug Administration (FDA) for phase II clinical trials for its independently-developed bisp...

August 11, 2025 | News

Axplora Invests €6.5 Million to Expand Vizag Facility as USFDA-Cleared Indian Sites Strengthen Global Strategy

Axplora, a global leader in API small molecule manufacturing, today announced a significant investment at its Vizag site in India to expand production ca...

August 06, 2025 | News

Minaris Advanced Therapies opens new GMP manufacturing facility in Munich to boost global cell and gene therapy capabilities

Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new...

August 05, 2025 | News

WuXi XDC’s New DP3 Facility Achieves GMP Release, Boosting Global Bioconjugate Manufacturing Capacity

WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...

August 05, 2025 | News

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics

Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...

August 04, 2025 | News

Asahi Kasei to Build New Planova™ Virus Filter Plant in Japan to Meet Surging Biopharma Demand

Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova&trad...

July 31, 2025 | News

AGC Biologics Partners with Valneva to Advance Phase II Shigella Vaccine Supply from Heidelberg Site

AGC Biologics, your friendly CDMO expert, announced a development and manufacturing services agreement with specialty vaccine company Valneva SE ...

July 31, 2025 | News

WuXi Biologics Begins Construction of One of the World’s Largest Modular Biologics Drug Product Facilities in Singapore

Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse ...

July 30, 2025 | News

AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment

Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in th...

July 22, 2025 | News

WuXi Biologics China PFS Site Clears FDA Inspection

WuXi Biologics’ pre-filled syringes (PFS) commercial production line passed its first FDA inspection, paving the way for global delivery of high-qu...

July 22, 2025 | News

Thermo Fisher to Acquire Sanofi’s Ridgefield Site, Expanding U.S. Steriles Manufacturing Capacity

Thermo Fisher to Acquire Sanofi’s Steriles Manufacturing Site in Ridgefield, New Jersey to Produce Critical Medicines for Sanofi Enables Additional ...

July 17, 2025 | News

Stay Connected